SEC Filing Summary: National Health Investors Inc (NHI)
Business Context and Reporting Period
This Form 8-K Current Report was filed by National Health Investors Inc on May 4, 2026. The filing serves to disclose supplemental information for the quarter ended March 31, 2026, pursuant to Regulation FD (Item 7.01). The company is incorporated in Maryland and its common stock trades on the New York Stock Exchange under the symbol NHI.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced "Supplemental Information" document (Exhibit 99.1) hosted on the company's website, which is not included in the provided text.
Material Changes
No material changes versus the prior comparable period are detailed in the body of this Form 8-K. The report acts solely as a notification that supplemental quarterly data has been released.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Investors are directed to the supplemental information exhibit for further details regarding the quarter's performance.
Investor Verification Checklist
- Verify the specific financial results for the quarter ended March 31, 2026, by reviewing Exhibit 99.1 on the company's website (www.nhireit.com).
- Confirm the accuracy of the supplemental data against the company's official press release or earnings presentation.
- Check for any subsequent filings that may update the supplemental information provided in this 8-K.